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Cell shape is an important biomarker that is directly linked to cell function. However, cell mor-
phodynamics, namely the temporal fluctuation of cell shape is much less understood. We study the
morphodynamics of MDA-MB-231 cells in type I collagen extracellular matrix (ECM). We find ECM
mechanics, as tuned by collagen concentration, controls the morphodynamics but not the static cell
morphology. We employ machine learning to classify cell shape into five different morphological phe-
notypes corresponding to different migration modes. As a result, cell morphodynamics is mapped
into temporal evolution of morphological phenotypes. We systematically characterize the phenotype
evolutions including occurrence probability, dwell time, transition flux, and 3D migrational charac-
teristics. We find that manipulating Rho-signaling enhances the morphodynamics and phenotype
transitions. Using a tumor organoid model, we show that the distinct invasion potentials of each
phenotype modulate the phenotype homeostasis. Overall invasion of a tumor organoid is facilitated
by individual cells searching for and committing to phenotypes of higher invasive potential. In con-
clusion, we show that 3D migrating cancer cells exhibit rich morphodynamics that is regulated by
ECM mechanics, Rho-signaling, and is closely related with cell motility. Our results pave the way
to the systematic characterization and functional understanding of cell morphodynamics as a new
biomarker for normal and malignant cells.
INTRODUCTION
Shape defines the cell. In the 1677 book Micrographia,
Robert Hooke showed sections within a herbaceous plant
under a microscope. The shape of those sections resem-
bles cells in a monastery, so he named the structures
cells [1]. Many breakthroughs followed Hooke’s discov-
ery, from the cell theory of Schwann and Schleiden, to the
theory of tissue formation by Remak, Virchow and Kol-
liker, and the theory of cellularpathologie by Virchow, all
of which are inspired by observations of cell shapes, or
morphology in general [2, 3].
In our modern view cell shape is determined by cell
function [4, 5]. A nerve cell has long branched protru-
sions for communication with other neurons; while the
cuboidal shape of epithelial cells allow them to tile the
surface of organs. Loss of characteristic shape, on the
other hand, is associated with functional abnormality.
Thus morphological characterization has been an impor-
tant tool for diagnosis such as in red blood cell disease [6],
neurological disease [7], and cancer [8, 9]. More recently,
cell shape analysis is boosted by techniques from com-
puter vision. As a result, it becomes possible to obtain
high content information of cellular states from morpho-
logical data alone [9–12].
While most research focuses on the static cell morphol-
ogy, the dynamic fluctuation of cell shape is much less un-
derstood. However, shape fluctuation – namely morpho-
dynamics, is of central importance for dynamic cellular
functions. The abnormal diffusion of small protrusions -
microvilli - on the surface of a T cell allows the T cell
to efficiently scan antigen-presenting surfaces [13]. For a
migrating cancer cell, morphodynamics drives the motil-
ity of the cell in many ways similar to our body frame
movements that enable swimming. In fact, just as there
are different swimming styles, cancer cells have been ob-
served to execute six different programs during invasion
in 3D tissue space [14]. Each program has distinct sig-
natures of morphology and morphodynamics, and are
usually referred to as migration phenotypes of filopodial,
lamellipodial, lobopodial, hemispherical blebbing, small
blebbing, and actin-enriched leading edge [15]. Cancer
cell migration phenotypes are controlled by intracellular
signaling such as the Rac and Rho-Rock-myosin path-
ways [16, 17], and extracellular factors such as the elastic-
ity, and degradability of the extracellular matrix (ECM)
[18, 19]. The ability of a cancer cell to switch between
migration phenotypes is important for tumor prognosis.
Many therapies, such as MMP inhibitors that target a
particular mode of cell motility, fail to stop tumor metas-
tasis largely because cells take other available migration
programs [20, 21].
In this paper, we study the morphodynamics of MDA-
MB-231 cells, a highly invasive human breast cancer cell
line in 3D collagen matrices. We find the shape fluctua-
tion is regulated by the mechanics of ECM. The cellular
morphodynamics not only drives 3D migration, but also
allows a single cell to sample multiple morphological phe-
notypes over a short amount of time. As a result, ECM
mechanics regulate the stability and transitions between
morphological phenotypes that corresponding to differ-
ent migration programs. We have measured the motility
of each morphological phenotype and find that pheno-
type transition facilitates invasiveness during 3D tumor
organoid invasion.
ar
X
iv
:1
80
7.
10
82
2v
2 
 [q
-b
io.
CB
]  
8 A
pr
 20
19
21
3
p
erim
eter
2
(1
0
4𝜇
𝑚
2
)
0
3
1
asp
ect ratio
time (hour)
0 25
A B
FIG. 1. Three-dimensional migration of MDA-MB-231 cells
is accompanied with significant cell shape fluctuation. (A) A
typical time lapse recording of 25 hours is projected onto a
single image with colors representing time. (B) The real space
(x-y plane), and shape space trajectories of 3 cells shown in
(A).
RESULTS
We find 3D migrating cancer cells rapidly sample their
available shape space. In order to quantify the cell mor-
phodynamics, we take time-lapse fluorescent images of
MDA-MB-231 cells migrating in collagen matrices. The
GFP labeled cells typically stay within the focal depth of
the objective lens (20X, NA 0.7) for 10-20 hours, while
we obtain 2D cell images at a rate of 4 frames per hour
(see SI Appendix section S1). After binarization and seg-
mentation, we compute geometric measures such as area,
perimeter, aspect ratio, and solidity which collectively
quantify the shape of a cell (see SI Appendix section S2).
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FIG. 2. Ensemble distribution of shape characteristics of
MDA-MB-231 cells in 3D (embedded in collagen gels) and
2D (on the top surfaces of collagen gels) cultures. The his-
tograms show relative probabilities (peak normalized to one)
of solidity, aspect ratio, and form factor. For each distribution
sample size N > 2000. ***: p <0.001, n.s.: not significant
(ANOVA). Color of the bars represent collagen concentration,
red: 1.5 mg/mL, and blue: 4.5 mg/mL.
The morphodynamics of a cell manifests itself as a ran-
dom walk in the geometric shape space concurrent with
its motility in the 3D matrix (Fig. 1). Because any cell
shape change boils down to the physical interactions be-
tween the cell and its environment, we hypothesize that
morphodynamics is sensitive to the physical properties of
the ECM. To test the hypothesis, we examine the shape
fluctuation of thousands of MDA-MB-231 cells in type I
collagen matrices of varying concentrations (see SI Ap-
pendix section S2). As we increase collagen concentration
from 1.5 mg/mL to 4.5 mg/mL, the storage modulus in-
creases by more than three folds (see SI Appendix section
S3).
We first examine if ensemble distributions of cell shape
shift as collagen concentration increases. To this end we
focus on three quantifies: solidity (ratio of the area and
its convex area), aspect ratio (ratio of the major and
minor axes lengths), and form factor (ratio of squared
perimeter and area) that are independent of imaging
scales. As shown in Fig. 2, these quantities are sharply
distributed for 3D migrating cells. However, none of the
three quantities show significant changes when collagen
concentration increases by 3-fold. This is in clear contrast
to MDA-MB-231 cells migrating on 2D surfaces. Consis-
tent with previous reports, when collagen concentration
increases from 1.5 mg/mL to 4.5 mg/mL, MDA-MB-231
cells exhibit lower solidity and higher form factor, as a
result of enhanced integrin-mediated adhesion and mem-
brane protrusions [22].
While the ensemble distributions of cell shape do not
distinguish between different collagen concentrations in
3D cultures, we find morphodynamics do. For 3D migrat-
ing cells we calculate their mean square displacements in
real space (σ2xy in Fig. 3A) and in shape space (σ
2
sol, σ
2
asp,
and σ2for in Fig. 3B-D). MDA-MB-231 cells show higher
diffusivity in real space at lower collagen concentration,
as is expected when matrix pore size is rate-limiting for
cell migration [23, 24].
Remarkably, cellular morphodynamics show clear de-
pendence on collagen concentrations. Over the time scale
of a few hours, σ2sol, σ
2
asp, and σ
2
for are approximately lin-
ear functions of time. Interestingly, diffusivity of solidity,
aspect ratio, and form factor are highest at intermedi-
ate collagen concentration (3.0 mg/mL), and are strongly
suppressed at collagen concentration of 4.5 mg/mL.
The fact that ECM mechanics significantly regulates
cellular morphodynamics, but not static cell shapes, may
be understood from a simple physical picture. The mor-
phodynamics of a cell may be considered as a random
walk over a complex potential landscape Ushape defined
over the cell shape space. At equilibrium, the distribu-
tion of static cell shape (Fig. 2) is determined by Ushape
while the speed of fluctuation (Fig. 3) is also influenced
by the effective viscosity. Keeping this simple picture in
mind, we conclude that for 2D migration ECM concen-
tration regulates the topography of the potential land-
scape while in 3D ECM concentration mainly affects the
effective viscocity.
Motivated by the mechanosensitivity of cell shape fluc-
tuation, we next seek to gain more insights by investigat-
ing a course-grained version of morphodynamics. To this
end, we train machine classifiers to divide the high dimen-
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FIG. 3. The mean square displacement (MSD) σ2 of MDA-
MB-231 cells in real space and in shape space as a function of
time t. (A) MSD of real space motility. σ2xy is obtained from
the x-y components of 3D cell trajectories. (B-D) MSDs char-
acterize the fluctuation of solidity (σ2sol), aspect ratio (σ
2
asp),
and form factor (σ2for). For each collagen concentration about
200 cells are analyzed.
sional cell shape space based on 3D cell migration pheno-
types. This is possible because different migration modes
are associated with distinct characteristic cell morpholo-
gies [14, 19].
We consider five morphological phenotypes including
two mesenchymal ones: filopodial (or FP in short) and
lamellipodial (LP); as well as three amoeboidal ones:
hemispherical blebbing (HS), small blebbing (SB), and
actin-enriched leading edge (AE). A sixth phenotype,
namely lobopodial or nuclear piston mode, has not been
observed in our experiments which is consistent with pre-
vious reports [25]. Once the classifier is trained, pheno-
type is determined automatically from a cell image if a
particular phenotype receives more than 70% probability
score. On the other hand, if none of the five phenotypes
receive more than 70% probability score, the cell is con-
sidered to be in an intermediate state.
We have trained two classifiers (see SI Appendix S4).
The first one is based on support vector machines (SVM
[26, 27]) involving 66 geometric measures. The second
one is based on a convolutional neural network architec-
ture that uses raw gray scale images as inputs [28]. Both
classifiers show good separation of training sets, more
than 90% of successful rates, and agree with each other
well on test data sets (Fig. 4A and SI Appendix S4).
Following, we mainly report the results from SVM algo-
rithm since it has intuitive interpretations directly from
the geometric measures.
The likelihoods of observing different morphological
phenotypes are remarkably different. At [col] = 1.5
mg/mL, HB, LP and SB shapes each account for more
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FIG. 4. MDA-MB-231 cells exhibit multiple morphological
phenotypes that are typically associated with distinct 3D mi-
gration modes. (A) An SVM classifier is trained based on
geometry of binarized cell images. A threshold of 70% proba-
bility is required for each phenotype classification, or the cell
is classified to be in intermediate state. To better visualize
the high dimensional geometric measures, we apply t-SNE
method [29] to generate a 3D projection of the cell shape
spaces. Different morphological phenotypes (insets show rep-
resentative images) are clearly separated. Scale bars of the
insets are 20 µm. (B) Percentage occurrence of each morpho-
logical phenotype (intermediate states account for approxi-
mately 30% occurrence in each collagen concentration). AE:
actin-enriched leading edge. FP: filopodial, LP: lamellipo-
dial, HS: hemispherical blebbing, SB: small blebbing. Colors
represent collagen concentration, red: 1.5 mg/mL, green: 3
mg/mL, blue: 4.5 mg/mL. For each collagen concentration
more than 3000 single cell images are analyzed.
than 15% of the observations, FP and AE phenotypes
only occur less than 5% of the time. We find increas-
ing collagen concentration increases the occurrence of HS
and SB cells, while decreasing the occurrence of LP cells.
This observation suggests that phenotype homeostasis of
MDA-MB-231 cells is regulated by ECM mechanics such
that stiffer ECM promotes higher probability of amoe-
boidal phenotypes.
To obtain further insights of cell morphodynamics, we
investigate the time evolution of morphological pheno-
types. Fig. 5A shows a typical time series of phenotype
dynamics where a cell switch directly from FP to LP
shape, then to SB shape via intermediate state. We first
examine the overall stability of cell shapes by measuring
the average dwell time a cell staying continuously either
in amoeboidal or mesenchymal states (see also SI Ap-
pendix S5). As shown in Fig. 5B, amoeboidal dwell time
T ad slightly increases with collagen concentration, while
mesenchymal dwell time Tmd decreases. At concentration
[col] = 1.5 mg/mL, Tmd = 3.8 hrs is more than twice
longer than T ad = 1.6 hrs. When collagen concentration
increases to 4.5 mg/mL, mesenchymal shapes become less
stable, and the corresponding dwell time (2.4 hrs) is only
30% longer than the amoeboidal dwell time (1.8 hrs).
To reveal the details of phenotype dynamics, we have
computed the transition rates as shown in Fig. 5C-D.
Surprisingly, we notice that while higher ECM concen-
tration extends the amoeboidal dwell time, it doesn’t
4slow down the phenotype dynamics at all. Instead, we
observe more frequent transitions along the HB-SB-AE
amoeboidal axes. For instance, the transition rates be-
tween HB and SB states at [col] = 4.5 mg/mL is 20%
higher than the rates at [col] = 1.5 mg/mL. While on
the contrary, the transition rates along the mesenchymal
axis FP-LP barely change when collagen concentration
increases by 3 folds.
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FIG. 5. Collagen concentration regulates the morphological
phenotype homeostasis of 3D migrating MDA-MB-231 cells.
(A) A sample time series of morphological phenotype. Insets:
three snapshots showing the GFP-labeled cell. Abbreviations:
F – filopodial, L – lamellipodial, I – intermediate state. (B)
The dwell times of amoeboidal (T ad , cyan) and mesenchymal
(Tmd , magenta) cell shapes have opposite dependence on col-
lagen concentration. (C-D) Graphical representation of the
transition matrix between different morphological phenotypes
at collagen concentration of 1.5 mg/mL (c) and 4.5 mg/ml
(D). The results of (B-D) are obtained by analyzing a total
of more than 6200 hours (four frames per hour) of single cell
morphodynamic trajectories. See also SI Appendix S5 for ad-
ditional details.
Results in Fig. 5C-D also reveal that the reduction of
mesenchymal dwell time Tmd at higher collagen concen-
tration is mainly due to the two-fold increase of transi-
tion rates from lamellipodial to amoeboidal states. This
is consistent with the mechanical model of blebbing for-
mation [30, 31]. A lamellipodial cell exhibits a prominent
cortical F-actin layer. Blebbs form when actomyosin con-
tractility exceeds the binding between cortical actin and
cell membrane. Our results suggest that the two compet-
ing forces exhibit higher fluctuation at increased ECM
concentration, fueling the transition between lamellipo-
dial and blebbing states.
On the other hand, we observe that filopodial cells have
very low transition rates to and from blebbing pheno-
types. Filopodial protrusions consist of elongated and
bundled actin fibers as a result of elevated actin poly-
merization and cross-linking by Ena/VASP proteins [32].
Fig. 5C-D suggest that the mechanical barrier separat-
ing filopodia and blebbing protrusions is too high for the
actomyosin contractility to overcome directly. Instead, a
FP cell can turn into a blebbing shape by first transform
into AE or LP states.
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FIG. 6. Morphodynamics of 3D cultured MDA-MB-231
cells under pharmacological perturbations of Rho-signaling.
(A) Representative morphological changes under treatment
of Y27632 or CN03. (B) The occurrence probabilities of each
morphological phenotypes after 8 hours of Y27632 (Rho↓) and
CN03 (Rho↑) treatments. (C-D) The mean square displace-
ment σ2 of solidity (C) and form factor (D) for native (non-
treated), Y27632-treated, and CN03-treated cells. (E) Trajec-
tories (thin gray lines) of cells in the t-SNE embedded shape
space. The trajectories start immediately after introducing
Y27632 or CN03, and ends after 8 hours of incubating with
the drugs. Converging paths are indicated with thick curves
with arrows as guide to the eyes. Two representative trajec-
tories per each treatment are highlighted with colored dots
connected by black lines, where color represents the instanta-
neous phenotype. Scattered light-colored dots show training
sets which is the same as in Fig. 4A. For each treatment ap-
proximately 100 cells are analyzed for their morphodynamics.
In order to understand the mechanisms underlying cell
morphological phenotype transitions, we examine the ef-
fects of manipulating Rho-signaling, which is a master
regulator that determines the mechanical state of a cell.
5To this end, we apply Y27632, a Rho-inhibitor; and
CN03, a Rho-activator to MDA-MB-231 cells cultured in
collagen ECM with concentration of 1.5 mg/mL (see SI
appendix S1). Consistent with previous reports, Y27632
reduces actomyosin contractility, promoting transitions
from blebbing to mesenchymal phenotypes [22]. On the
other hand, CN03 elevates myosin II activity, leading to
retraction of filopodia to rounded cell shapes (Fig. 6A).
We find that after the treatment, occurrence probabili-
ties of morphological phenotypes are markedly distinct
from the native (non-treated) cells (Fig. 6B). Perturb-
ing the Rho signaling in both directions encourage the
cells to sample their shape space more dynamically (Fig.
6C-D). As a result, both Y27632 and CN03 treatments
allow the cells to more frequently visit otherwise hard to
access states such as FP and AE. Invigorated by the per-
turbations, MDA-MB-231 cells exhibit reduced disparity
in the phenotype occurrence probabilities compared with
the native (non-treated) group.
Tracking the phenotype evolution at single cell resolu-
tion further reveals the shape trajectories of MDA-MB-
231 cells under perturbations (Fig. 6E). Despite fluc-
tuations among individual cells, we find strong conver-
gence of trajectories in cell shape space (Fig. 6E thick
arrows). These converged paths are presumably the most
biomechanically favorable. Consistent with our results in
Fig. 5, AE state is heavily accessed as a gateway to FP
state when cells are treated with Y27632. When treated
with CN03, AE is at the fork of two bifurcating direc-
tions where one lead to LP, and the other lead to HB/SB
states. These results suggest that AE state, which ex-
hibits weak cell-ECM adhesions and F-actin rich protru-
sions [33, 34], mediate Rho-signaling controlled transi-
tions between mesenchymal and amoeboidal motility.
Having analyzed the morphodynamics of MDA-MB-
231 cells in 3D matrices, we next examine the invasion
potential of each morphological phenotype. To this end,
we model the migration of a cell as a polarized persistent
random walk [35]. Because the finite dwell time of each
phenotype limits the length of trajectories, we measure
step size distribution as an alternative of autocorrelation
analysis in order to extract the diffusivity and persistence
of cell motility for each phenotype.
We consider one-hour segments of cell trajectories di-
vided into two half-hour sections. Assuming the average
cell velocity during the first section is along xˆ direction,
we find the displacement δd of the cell in the second sec-
tion well described as
δd = d‖xˆ+ d⊥yˆ
= W (v‖δt,D‖δt)xˆ+W (0, D⊥δt)yˆ, (1)
where δt = 0.5 hour, W (µ, σ2) is a Wiener process of
drift µ and variance σ2 (See also SI Appendix S6). D‖
and D⊥ are effective diffusion coefficients of the cell in
two orthogonal directions: one that is parallel to the pre-
vious step, and one that is perpendicular to the previous
step. v‖ is the persistent velocity, which quantifies the
tendency of a cell to keep its migration direction.
We find overall filopodial cells have the highest rate of
persist migration (Fig. 7A-B and SI Appendix S6), while
SB mode is the least motile. The phenotype-dependent
motility is also tuned by the ECM mechanics. In par-
ticular, v‖ and D‖ are maximal at intermediate collagen
concentration for mesenchymal modes (3 mg/ml), but the
trend is not present for amoeboidal modes. Previously it
was reported that MDA-MB-231 cell invasion is most ef-
ficient at intermediate collagen concentration [36]. Here
we show that mesenchymal motility is mostly responsible
for such non-monotonic dependence.
Persistent motility predicts the invasion potential of
cancer cells. Because of the observed phenotype tran-
sitions (Fig. 5), we expect that phenotype homeosta-
sis is coupled with invasion. In particular, we hypoth-
esize a population selected for higher invasion potential
will have different phenotype occurrence probability com-
pared with the random migration assays in Fig. 4.
To test the hypothesis, we study the invasion of a tu-
mor diskoid into ECM of 1.5 mg/ml type I collagen [37].
The diskoid of 500 µm in diameter consists of ≈ 1500
tightly packed MDA-MB-231 cells. Over the course of
5 days, cells disseminate into the ECM as deep as 400
µm from the original tumor. Fig. 7C shows a snapshot
taken on the fifth day of the invading diskoid (See also
SI Appendix S7).
We examine the morphological phenotype of all cells
that have disseminated from the original tumor. Consis-
tent with our hypothesis, this more invasive population
favors AE and FP modes, which have the highest persis-
tent motility at [col]=1.5 mg/ml as shown in Fig. 7A-B.
On the other hand, the slow moving SB modes only ac-
count for 8% of the population disseminated from the
original tumor organoid. The shift of phenotype home-
ostasis is especially striking when comparing Fig. 4B and
Fig. 6C, where the most and least probable phenotypes
are opposite in these two situations.
DISCUSSION
In this paper, we report the morphodynamics of MDA-
MB-231 cells in type I collagen ECM as a model sys-
tem of metastatic cancer cells migrating in 3D tissue.
MDA-MB-231 cells rapidly sample their possible geom-
etry, therefore exhibiting simultaneous random walks in
both real space and shape space (Fig. 1). When ECM
mechanics are tuned by varying collagen concentration,
we find dramatic changes in the cellular morphodynam-
ics, but not in the ensemble distributions of cell shapes
(Fig. 2 and Fig. 3). On the other hand, when the cells
migrate on the surfaces of collagen ECM, their shape
distributions do shift as collagen concentration increases.
The contrast is particularly striking noticing that almost
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FIG. 7. The morphological phenotype determines 3D inva-
sive potential of MDA-MB-231 cells. (A-B) Persistence and
diffusivity of each morphological phenotype in ECM of vary-
ing collagen concentrations. For each condition, v‖ and D‖
are obtained by fitting the cumulative distribution function
of samples with N >1000. The errorbars are 95% confidence
intervals of the fitting parameters. See also SI Appendix S6
for more details. (C) Phenotype composition of cells dissemi-
nated from the original tumor organoid at day 5 after seeding
the cells. Left: a confocal imaging snapshot of an organoid
taken at day 5. Cells that have disseminated into the ECM are
color-labeled by their phenotype classification. Right: pheno-
type composition of disseminating cells.
the same set of molecular machineries are involved in
both 2D and 3D cell migration, shape regulation and
mechanosensing [38, 39].
The biological significance of the morphodynamics is
further demonstrated by classifying cell shapes into mor-
phological phenotypes corresponding to different migra-
tion programs. While the occurrence and dwell time of
blebbing phenotypes increases with collagen concentra-
tion, mesenchymal shapes become less stable and prob-
able (Fig. 4 and Fig. 5). Interestingly, accompany-
ing these two opposite trends is the increased transition
rates among morphological phenotypes that are elevated
at higher collagen concentration (Fig. 5).
Our results also shed light to the control mechanism
of cell motility phenotypes. In particular, we show that
perturbing the Rho-signaling dramatically modulates the
cell morphodynamics (Fig. 6). It has been shown previ-
ously that Rac and Rho signaling regulates the shift be-
tween lamellipodial and blebbing motility [16, 18]. Com-
plement to these results, our analysis further reveal that
instead of stabilizing a particular mode of motility, per-
turbation of Rho signaling invigorates the morphody-
namics of cells. As a result, cells exhibit more dynamic
shape fluctuations and more aggressively explore the dif-
ferent morphological phenotypes. We also find that AE
state mediate the Rho-signaling controlled transitions be-
tween different phenotypes, further illuminating the un-
derlying phenotype landscape that controls cancer cell
3D motility.
In light of the rapid phenotype transitions exhibited by
individual cells, 3D cancer cell motility may be consid-
ered as a hidden Markov process where each phenotype is
associated with characteristic diffusivity and persistence.
In this perspective morphodynamics facilitates cancer in-
vasion because phenotype transitions allow cancer cells to
search for and commit to a more invasive phenotype (Fig.
7), [40].
In summary, we demonstrate the morphodynamics of
3D migrating cancer cells as a powerful tool to inspect
the internal state and microenvironment of the cells. In
order to further exploit the information provided by the
cell shape fluctuations, future research is needed to de-
code morphodynamics as a rich body language of cells,
and to control morphodynamics as a route of mechanical
programming of cell phenotype.
MATERIALS AND METHODS
See SI Appendix S1 for details of 3D cell culture, mi-
croscopy, and pharmacological treatments.
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